Stimulating the development of mechanism-based, individualized pain therapies (Q43066442)

13 November 2017

1 reference

title

Stimulating the development of mechanism-based, individualized pain therapies (English)

1 reference

13 November 2017

1

Janet Woodcock

1 reference

13 November 2017

James Witter

2

1 reference

PubMed ID

17762885

13 November 2017

Raymond A Dionne

series ordinal

3

1 reference

13 November 2017

1 September 2007

1 reference

Nature Reviews Drug Discovery

13 November 2017

1 reference

13 November 2017

6

1 reference

13 November 2017

9

1 reference

13 November 2017

703-710

1 reference

https://scigraph.springernature.com/pub.10.1038/nrd2335

13 November 2017

0 references

cites work

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

1 reference

Mechanisms of neuropathic pain and their implications for the design of clinical trials

21 January 2018

1 reference

NIH-FDA Analgesic Drug Development Workshop: translating scientific advances into improved pain relief

21 January 2018

1 reference

Individual responder analyses for pain: does one pain scale fit all?

31 March 2020

1 reference

31 March 2020

1 reference

Glia: a novel drug discovery target for clinical pain

31 March 2020

1 reference

Dynamic regulation of the proinflammatory cytokine, interleukin-1beta: molecular biology for non-molecular biologists

31 March 2020

1 reference

Cellular signalling pathways of spinal pain neuroplasticity as targets for analgesic development

31 March 2020

1 reference

p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury

31 March 2020

1 reference

Neural-glial interaction in the spinal cord for the development and maintenance of nerve injury-induced neuropathic pain

31 March 2020

1 reference

Pharmacogenetics and drug development: the path to safer and more effective drugs

31 March 2020

1 reference

Pharmacophylogenomics: genes, evolution and drug targets

31 March 2020

1 reference

The impact of genomics on drug discovery

31 March 2020

1 reference

Genetic influence on variability in human acute experimental pain sensitivity associated with gender, ethnicity and psychological temperament

31 March 2020

1 reference

Effects of the 2-amino-3-hydroxy-5-methyl-4-isoxazole-proprionic acid/kainate antagonist LY293558 on spontaneous and evoked postoperative pain

31 March 2020

1 reference

The search for a better analgesic.

31 March 2020

1 reference

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

31 March 2020

1 reference

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

31 March 2020

1 reference

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

31 March 2020

1 reference

Coxibs and cardiovascular disease

31 March 2020

1 reference

COX-2 inhibitors--lessons in drug safety

31 March 2020

1 reference

Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors

31 March 2020

1 reference

From monoamines to genomic targets: a paradigm shift for drug discovery in depression

31 March 2020

1 reference

Evolving ways that drug therapy is individualized.

31 March 2020

1 reference

Paving the critical path: how can clinical pharmacology help achieve the vision?

31 March 2020

1 reference

Neural correlates of interindividual differences in the subjective experience of pain

31 March 2020

1 reference

Individual differences in pain sensitivity: implications for treatment decisions

31 March 2020

1 reference

Neural circuitry underlying pain modulation: expectation, hypnosis, placebo

31 March 2020

1 reference

Age differences in postoperative pain are scale dependent: a comparison of measures of pain intensity and quality in younger and older surgical patients

31 March 2020

1 reference

31 March 2020

Sex differences in pain

1 reference

31 March 2020

1 reference

Sex differences in thermal nociception and morphine antinociception in rodents depend on genotype

31 March 2020

1 reference

Relationships between measurement of pain using visual analog score and morphine requirements during postoperative intravenous morphine titration

31 March 2020

1 reference

Core outcome domains for chronic pain clinical trials: IMMPACT recommendations

31 March 2020

1 reference

Core outcome measures for chronic pain clinical trials: IMMPACT recommendations

31 March 2020

1 reference

Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations

31 March 2020

1 reference

Genetically mediated interindividual variation in analgesic responses to cyclooxygenase inhibitory drugs

31 March 2020

1 reference

Response and remission rates in different subpopulations with major depressive disorder administered venlafaxine, selective serotonin reuptake inhibitors, or placebo

31 March 2020

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NRD2335

1 reference

PubMed ID

17762885

Dimensions Publication ID

13 November 2017

0 references

1 reference

PubMed ID

17762885